Endocrine Abstracts

Aims: We present final Hellenic data from the INSTIGATE study on direct costs of care and resource use, over the 24 months after insulin initiation, in type 2 diabetic (T2D) patients.Methods: INSTIGATE, a prospective European observational study involving T2D patients who initiated insulin during usual care, assessed direct costs of care over the 6 months prior to and for the intervals from baseline to 6 months, 6–12, 12–18 and 18–24 month...

Aims: We present final Hellenic data from the INSTIGATE study which assessed direct costs, resource utilisation, and clinical outcomes in the first 24 months of insulin therapy in type 2 diabetic (T2D) patients.Methods: INSTIGATE was a prospective European observational study of patients with type 2 diabetes who had initiated insulin during usual care. Data were collected at baseline, when subjects initiated insulin (visit T1), then 3 (T2), 6 (T3), 12 (T...

Purpose: Diabetic patients (T2D) switch from short-acting insulin to rapid-acting analogue (H-A) and less commonly from A-H. The SWING study was designed to assess treatment costs, glucose control, satisfaction, and quality of life in T2D following H-A or A-H switches.Methods: SWING was a multinational, prospective, observational study of previously mentioned parameters associated with switching in either direction between any rapid-acting analogue insul...